Partial replicate designs [RSABE / ABEL]

posted by The Outlaw Torn – Europe, 2013-09-25 13:10 (4660 d 17:38 ago) – Posting: # 11558
Views: 6,667

Hello again,

❝ First, the partial replicate is TRR|RTR|RRT – which is a lousy design. I would opt for a full replicate with three periods (RTR|TRT). Similar sample size/costs, more information.


Don't mean to interupt your "vacation" in beautiful Jordan, but if you have "nothing better to do--it's not like they have good falafels or kebabs there" :hungry: mind explaining why it's a lousy design?

❝ ❝ The second thing is the following. What is the sample size estimate for a drug (not Schützomycin) with a intra-subject variability of 37.5%? And how would those subjects be distributed per group in said partial replicate?


So, only 15 or 16 subjects per groups, eh? Hmmmm. Would have expected more. I'll have to do a bit more head wrapping and may have a follow-up.

Thanks for everything. And enjoy Amman.

Take care,
Outlaw Torn

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
265 visitors (0 registered, 265 guests [including 26 identified bots]).
Forum time: 06:48 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5